 | • レポートコード：MRC23Q35826 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（2-3日） • 産業分類：産業機械 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のバイオ医薬品サービス市場について調査・分析し、世界のバイオ医薬品サービス市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（原材料、製造工程・製品、医薬品完成品、その他）、用途別セグメント分析（分析試験、医薬品開発サービス、医薬品包装＆配送、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Eurofins、Pace Analytical Services、Catalent、Envigo、PPD、Element、ALS、Intertek、SGS、Boston Analytical、EAG、Maxxam、ARL Bio Pharma、West Pharmaceutical、BioScreen、Microbac、RD Laboratories、Analytical Lab Group、Piramal Pharma Solutionsなどが含まれています。世界のバイオ医薬品サービス市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、バイオ医薬品サービス市場規模を推定する際に考慮しました。本レポートは、バイオ医薬品サービスの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、バイオ医薬品サービスに関するビジネス上の意思決定に役立てることを目的としています。 ・バイオ医薬品サービス市場の概要 - バイオ医薬品サービスのタイプ別セグメント - 世界のバイオ医薬品サービス市場規模：タイプ別分析（原材料、製造工程・製品、医薬品完成品、その他） - バイオ医薬品サービスの用途別セグメント - 世界のバイオ医薬品サービス市場規模：用途別分析（分析試験、医薬品開発サービス、医薬品包装＆配送、その他） - 世界のバイオ医薬品サービス市場規模予測（2018年-2029年） ・バイオ医薬品サービス市場の成長トレンド - バイオ医薬品サービスの地域別市場規模（2018年-2029年） - バイオ医薬品サービス市場ダイナミクス - バイオ医薬品サービスの業界動向 - バイオ医薬品サービス市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：原材料、製造工程・製品、医薬品完成品、その他 - 世界のバイオ医薬品サービスのタイプ別市場規模（2018年-2023年） - 世界のバイオ医薬品サービスのタイプ別市場規模（2024年-2029年） ・用途別セグメント：分析試験、医薬品開発サービス、医薬品包装＆配送、その他 - 世界のバイオ医薬品サービスの用途別市場規模（2018年-2023年） - 世界のバイオ医薬品サービスの用途別市場規模（2024年-2029年） ・バイオ医薬品サービスの地域別市場規模 - 北米のバイオ医薬品サービス市場規模（2018年-2029年） - アメリカのバイオ医薬品サービス市場規模（2018年-2029年） - ヨーロッパのバイオ医薬品サービス市場規模（2018年-2029年） - アジア太平洋のバイオ医薬品サービス市場規模（2018年-2029年） - 中国のバイオ医薬品サービス市場規模（2018年-2029年） - 日本のバイオ医薬品サービス市場規模（2018年-2029年） - 韓国のバイオ医薬品サービス市場規模（2018年-2029年） - インドのバイオ医薬品サービス市場規模（2018年-2029年） - オーストラリアのバイオ医薬品サービス市場規模（2018年-2029年） - 中南米のバイオ医薬品サービス市場規模（2018年-2029年） - 中東・アフリカのバイオ医薬品サービス市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Eurofins、Pace Analytical Services、Catalent、Envigo、PPD、Element、ALS、Intertek、SGS、Boston Analytical、EAG、Maxxam、ARL Bio Pharma、West Pharmaceutical、BioScreen、Microbac、RD Laboratories、Analytical Lab Group、Piramal Pharma Solutions ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global BioPharma Service market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for BioPharma Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for BioPharma Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for BioPharma Service in Analytical Testing is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of BioPharma Service include Eurofins, Pace Analytical Services, Catalent, Envigo, PPD, Element, ALS, Intertek and SGS, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for BioPharma Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BioPharma Service.
The BioPharma Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global BioPharma Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BioPharma Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Eurofins
Pace Analytical Services
Catalent
Envigo
PPD
Element
ALS
Intertek
SGS
Boston Analytical
EAG
Maxxam
ARL Bio Pharma
West Pharmaceutical
BioScreen
Microbac
RD Laboratories
Analytical Lab Group
Piramal Pharma Solutions
Segment by Type
Raw Material
In-Process and Product
Finished Pharmaceutical
Others
Segment by Application
Analytical Testing
Drug Development Service
Drug Packaging and Delivery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of BioPharma Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global BioPharma Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Raw Material
1.2.3 In-Process and Product
1.2.4 Finished Pharmaceutical
1.2.5 Others
1.3 Market by Application
1.3.1 Global BioPharma Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Analytical Testing
1.3.3 Drug Development Service
1.3.4 Drug Packaging and Delivery
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global BioPharma Service Market Perspective (2018-2029)
2.2 BioPharma Service Growth Trends by Region
2.2.1 Global BioPharma Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 BioPharma Service Historic Market Size by Region (2018-2023)
2.2.3 BioPharma Service Forecasted Market Size by Region (2024-2029)
2.3 BioPharma Service Market Dynamics
2.3.1 BioPharma Service Industry Trends
2.3.2 BioPharma Service Market Drivers
2.3.3 BioPharma Service Market Challenges
2.3.4 BioPharma Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top BioPharma Service Players by Revenue
3.1.1 Global Top BioPharma Service Players by Revenue (2018-2023)
3.1.2 Global BioPharma Service Revenue Market Share by Players (2018-2023)
3.2 Global BioPharma Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by BioPharma Service Revenue
3.4 Global BioPharma Service Market Concentration Ratio
3.4.1 Global BioPharma Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by BioPharma Service Revenue in 2022
3.5 BioPharma Service Key Players Head office and Area Served
3.6 Key Players BioPharma Service Product Solution and Service
3.7 Date of Enter into BioPharma Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 BioPharma Service Breakdown Data by Type
4.1 Global BioPharma Service Historic Market Size by Type (2018-2023)
4.2 Global BioPharma Service Forecasted Market Size by Type (2024-2029)
5 BioPharma Service Breakdown Data by Application
5.1 Global BioPharma Service Historic Market Size by Application (2018-2023)
5.2 Global BioPharma Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America BioPharma Service Market Size (2018-2029)
6.2 North America BioPharma Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America BioPharma Service Market Size by Country (2018-2023)
6.4 North America BioPharma Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe BioPharma Service Market Size (2018-2029)
7.2 Europe BioPharma Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe BioPharma Service Market Size by Country (2018-2023)
7.4 Europe BioPharma Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific BioPharma Service Market Size (2018-2029)
8.2 Asia-Pacific BioPharma Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific BioPharma Service Market Size by Region (2018-2023)
8.4 Asia-Pacific BioPharma Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America BioPharma Service Market Size (2018-2029)
9.2 Latin America BioPharma Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America BioPharma Service Market Size by Country (2018-2023)
9.4 Latin America BioPharma Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa BioPharma Service Market Size (2018-2029)
10.2 Middle East & Africa BioPharma Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa BioPharma Service Market Size by Country (2018-2023)
10.4 Middle East & Africa BioPharma Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins
11.1.1 Eurofins Company Detail
11.1.2 Eurofins Business Overview
11.1.3 Eurofins BioPharma Service Introduction
11.1.4 Eurofins Revenue in BioPharma Service Business (2018-2023)
11.1.5 Eurofins Recent Development
11.2 Pace Analytical Services
11.2.1 Pace Analytical Services Company Detail
11.2.2 Pace Analytical Services Business Overview
11.2.3 Pace Analytical Services BioPharma Service Introduction
11.2.4 Pace Analytical Services Revenue in BioPharma Service Business (2018-2023)
11.2.5 Pace Analytical Services Recent Development
11.3 Catalent
11.3.1 Catalent Company Detail
11.3.2 Catalent Business Overview
11.3.3 Catalent BioPharma Service Introduction
11.3.4 Catalent Revenue in BioPharma Service Business (2018-2023)
11.3.5 Catalent Recent Development
11.4 Envigo
11.4.1 Envigo Company Detail
11.4.2 Envigo Business Overview
11.4.3 Envigo BioPharma Service Introduction
11.4.4 Envigo Revenue in BioPharma Service Business (2018-2023)
11.4.5 Envigo Recent Development
11.5 PPD
11.5.1 PPD Company Detail
11.5.2 PPD Business Overview
11.5.3 PPD BioPharma Service Introduction
11.5.4 PPD Revenue in BioPharma Service Business (2018-2023)
11.5.5 PPD Recent Development
11.6 Element
11.6.1 Element Company Detail
11.6.2 Element Business Overview
11.6.3 Element BioPharma Service Introduction
11.6.4 Element Revenue in BioPharma Service Business (2018-2023)
11.6.5 Element Recent Development
11.7 ALS
11.7.1 ALS Company Detail
11.7.2 ALS Business Overview
11.7.3 ALS BioPharma Service Introduction
11.7.4 ALS Revenue in BioPharma Service Business (2018-2023)
11.7.5 ALS Recent Development
11.8 Intertek
11.8.1 Intertek Company Detail
11.8.2 Intertek Business Overview
11.8.3 Intertek BioPharma Service Introduction
11.8.4 Intertek Revenue in BioPharma Service Business (2018-2023)
11.8.5 Intertek Recent Development
11.9 SGS
11.9.1 SGS Company Detail
11.9.2 SGS Business Overview
11.9.3 SGS BioPharma Service Introduction
11.9.4 SGS Revenue in BioPharma Service Business (2018-2023)
11.9.5 SGS Recent Development
11.10 Boston Analytical
11.10.1 Boston Analytical Company Detail
11.10.2 Boston Analytical Business Overview
11.10.3 Boston Analytical BioPharma Service Introduction
11.10.4 Boston Analytical Revenue in BioPharma Service Business (2018-2023)
11.10.5 Boston Analytical Recent Development
11.11 EAG
11.11.1 EAG Company Detail
11.11.2 EAG Business Overview
11.11.3 EAG BioPharma Service Introduction
11.11.4 EAG Revenue in BioPharma Service Business (2018-2023)
11.11.5 EAG Recent Development
11.12 Maxxam
11.12.1 Maxxam Company Detail
11.12.2 Maxxam Business Overview
11.12.3 Maxxam BioPharma Service Introduction
11.12.4 Maxxam Revenue in BioPharma Service Business (2018-2023)
11.12.5 Maxxam Recent Development
11.13 ARL Bio Pharma
11.13.1 ARL Bio Pharma Company Detail
11.13.2 ARL Bio Pharma Business Overview
11.13.3 ARL Bio Pharma BioPharma Service Introduction
11.13.4 ARL Bio Pharma Revenue in BioPharma Service Business (2018-2023)
11.13.5 ARL Bio Pharma Recent Development
11.14 West Pharmaceutical
11.14.1 West Pharmaceutical Company Detail
11.14.2 West Pharmaceutical Business Overview
11.14.3 West Pharmaceutical BioPharma Service Introduction
11.14.4 West Pharmaceutical Revenue in BioPharma Service Business (2018-2023)
11.14.5 West Pharmaceutical Recent Development
11.15 BioScreen
11.15.1 BioScreen Company Detail
11.15.2 BioScreen Business Overview
11.15.3 BioScreen BioPharma Service Introduction
11.15.4 BioScreen Revenue in BioPharma Service Business (2018-2023)
11.15.5 BioScreen Recent Development
11.16 Microbac
11.16.1 Microbac Company Detail
11.16.2 Microbac Business Overview
11.16.3 Microbac BioPharma Service Introduction
11.16.4 Microbac Revenue in BioPharma Service Business (2018-2023)
11.16.5 Microbac Recent Development
11.17 RD Laboratories
11.17.1 RD Laboratories Company Detail
11.17.2 RD Laboratories Business Overview
11.17.3 RD Laboratories BioPharma Service Introduction
11.17.4 RD Laboratories Revenue in BioPharma Service Business (2018-2023)
11.17.5 RD Laboratories Recent Development
11.18 Analytical Lab Group
11.18.1 Analytical Lab Group Company Detail
11.18.2 Analytical Lab Group Business Overview
11.18.3 Analytical Lab Group BioPharma Service Introduction
11.18.4 Analytical Lab Group Revenue in BioPharma Service Business (2018-2023)
11.18.5 Analytical Lab Group Recent Development
11.19 Piramal Pharma Solutions
11.19.1 Piramal Pharma Solutions Company Detail
11.19.2 Piramal Pharma Solutions Business Overview
11.19.3 Piramal Pharma Solutions BioPharma Service Introduction
11.19.4 Piramal Pharma Solutions Revenue in BioPharma Service Business (2018-2023)
11.19.5 Piramal Pharma Solutions Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details